Watkins Linimax: Alternative to Vioxx

On Thursday, September 30, 2004, Merck & Company Pharmaceuticals announced a worldwide recall of Vioxx, a top-selling arthritis and pain medication drug. This recall was based on evidence that showed an increased risk of heart attack and stroke after 18 months of use. Millions of people take either Vioxx or a similar drug, Celebrex, for relief of arthritis pain. Although there is no recall on Celebrex at this time, its similarity to Vioxx has raised concerns among health professionals and patients.

Watkins Linimax
Watkins Linimax® contains glucosamie. For over 25 years, physicians around the world have prescribed glucosamine for joint discomfort.
Sales of Vioxx worldwide were $2.5 billion in 2003, and those who depended on Vioxx for pain relief will now be looking for an alternative, and you can help! Watkins Linimax (#02266 US / #32116 CDN) contains glucosamine, a natural compound found in the body that stimulates the production of cartilage and inhibits its breakdown, resulting in less joint discomfort and swelling, and greater movement and joint flexibility. For over 25 years, physicians around the world have prescribed glucosamine for joint discomfort for one simple reason: People who take it feel better, and experience no side effects. Watkins Linimax contains the purest form of glucosamine, along with other natural soothing and protective ingredients, including antioxidants from whole grape extract, along with ginger, boswellia and curcumin, shown to reduce the body's production of pain-causing compounds.*

For safe and effective relief, Watkins has the answer, in Linimax!

For more information and testimonials on Watkins Linimax, refer to the Linimax Product Profile Page at www.WatkinsOnline.com/councell or www.realvanilla.com to locate an associate.

Consult your physician before taking any dietary supplement.

*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

 

What did you think of this article?

Liked
Disliked
No Opinion